Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
55,705,828
-
Total 13F shares
-
9,265,285
-
Share change
-
+164,847
-
Total reported value
-
$118,611,567
-
Price per share
-
$12.81
-
Number of holders
-
53
-
Value change
-
+$3,650,412
-
Number of buys
-
24
-
Number of sells
-
22
Institutional Holders of Spero Therapeutics, Inc. - Common Stock, par value $0.001 per share (SPRO) as of Q1 2019
As of 31 Mar 2019,
Spero Therapeutics, Inc. - Common Stock, par value $0.001 per share (SPRO) was held by
53 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,265,285 shares.
The largest 10 holders included
Atlas Venture Associates IX, LLC, Alphabet Inc., Aquilo Capital Management, LLC, Artal Group S.A., AWM Investment Company, Inc., Rock Springs Capital Management LP, ORBIMED ADVISORS LLC, VHCP Management II, LLC, BVF INC/IL, and BlackRock Inc..
This page lists
53
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.